Congress trades

bluebird bio, Inc. (BLUE)

NASDAQ · Healthcare · 8 congress trades · last filed 6 years agono longer trading under this ticker

8
Congress disclosures shown
22d
Median delay on the congress disclosures
of the 45 day limit
4 buys·4 sells
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades BLUE.

Free on iOS and Android.

About bluebird bio, Inc.

from the company's filings and listing, as of Oct 21, 2026
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Chief executive
-
Employees
248
Listed since
Jun 19, 2013
Market value
$48.7Mlast quoted Jun 2, 2025
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-
Dividend yield
-

www.genetixbiotx.com

Earnings

6 reported quarters
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q1 FY2025reported May 14, 2025-$3.74-$3.29$30.0M$38.7MEPS missRevenue miss
Q4 FY2024reported Mar 27, 2025-$5.60-$6.15$25.3M$27.2MEPS beatRevenue miss
Q3 FY2024reported Nov 14, 2024-$6.20-$7.28$10.6M$18.1MEPS beatRevenue miss
Q2 FY2024reported Aug 14, 2024-$8.40-$7.28$16.1M$24.3MEPS missRevenue miss
Q1 FY2024reported May 9, 2024-$7.60n/a$18.6M$19.3MEPS n/aRevenue miss
Q4 FY2023reported Mar 26, 2024-$11.80n/a$7.8M$16.8MEPS n/aRevenue miss

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A figure or flag reads n/a when a number is missing, or when the figure failed our check against the company's other quarters, its own filings and its share splits, and was left out. An estimate is a forecast made by analysts, not a company target.

Know when the next BLUE filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in BLUE

8 disclosures of 8 on record · median 22d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Lois FrankelStockSale$1,001 - $15,000n/aPrice history ends Jun 2, 2025Dec 10, 2020Dec 28, 202018d
Lois FrankelStockSale$1,001 - $15,000n/aPrice history ends Jun 2, 2025Dec 11, 2020Dec 28, 202017d
Lois FrankelStockPurchase$1,001 - $15,000n/aPrice history ends Jun 2, 2025Jul 15, 2020Jul 24, 20209d
Lois FrankelStockPurchase$1,001 - $15,000n/aPrice history ends Jun 2, 2025Apr 27, 2020May 28, 202031d
Ro KhannaStockSale$1,001 - $15,000n/aPrice history ends Jun 2, 2025Sep 16, 2019Oct 16, 201930d
Ro KhannaStockPurchase$1,001 - $15,000n/aPrice history ends Jun 2, 2025Jun 3, 2019Jul 11, 201938d
Ro KhannaStockSale$1,001 - $15,000n/aPrice history ends Jun 2, 2025Dec 17, 2018Jan 11, 201925d
Ro KhannaStockPurchase$1,001 - $15,000n/aPrice history ends Jun 2, 2025Oct 25, 2018Nov 9, 201815d

We hold no closing prices for any row shown here, so no move is shown. Not investment advice.

Every Congress trade in BLUE, filterable by party, chamber, type and account.

Questions

Which members of Congress have traded BLUE?

Lois Frankel and Ro Khanna disclosed BLUE transactions in the filings shown here.

How quickly are BLUE trades disclosed?

Congressional disclosures took a median of 22 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 27, 2026.

Related companies

traded by the same members

See every company we track